➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Baxter
Merck
Boehringer Ingelheim
Colorcon

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Vadadustat


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Vadadustat?

Vadadustat is an investigational drug.

There have been 27 clinical trials for Vadadustat. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2015.

The most common disease conditions in clinical trials are Anemia, Renal Insufficiency, Chronic, and Kidney Diseases. The leading clinical trial sponsors are Akebia Therapeutics, Mitsubishi Tanabe Pharma Corporation, and The University of Texas Health Science Center, Houston.

There are twenty-nine US patents protecting this investigational drug and two hundred and fifty-nine international patents.

Recent Clinical Trials for Vadadustat
TitleSponsorPhase
Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis SubjectsAkebia TherapeuticsPhase 3
Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)Akebia Therapeutics Inc.Phase 2
Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)The University of Texas Health Science Center, HoustonPhase 2

See all Vadadustat clinical trials

Clinical Trial Summary for Vadadustat

Top disease conditions for Vadadustat
Top clinical trial sponsors for Vadadustat

See all Vadadustat clinical trials

US Patents for Vadadustat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Vadadustat   Try Before You Buy Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryloxy or heteroaryloxy, preparation method thereof and pharmaceutical use thereof SHENYANG SUNSHINE PHARMACEUTICAL CO. LTD. (Shenyang, Liaoning, CN)   Try Before You Buy
Vadadustat   Try Before You Buy Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Try Before You Buy
Vadadustat   Try Before You Buy Compound of 3-hydroxyl pyridine, preparation method thereof and pharmaceutical use thereof SHENYANG SUNSHINE PHARMACEUTICAL CO. LTD. (Shenyang, CN)   Try Before You Buy
Vadadustat   Try Before You Buy Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof Akebia Therapeutics, Inc. (Cambridge, MA)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Vadadustat

Drugname Country Document Number Estimated Expiration Related US Patent
Vadadustat China CN106146490 2035-03-27   Try Before You Buy
Vadadustat European Patent Office EP3275881 2035-03-27   Try Before You Buy
Vadadustat Japan JP2018513144 2035-03-27   Try Before You Buy
Vadadustat Japan JP6556861 2035-03-27   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
McKinsey
Johnson and Johnson
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.